超声引导下经皮微创消融治疗甲状腺结节的应用

马树花

doi:10.12122/j.issn.1674-4500.2018.03.03

超声引导下经皮微创消融治疗甲状腺结节的应用

doi: 10.12122/j.issn.1674-4500.2018.03.03

马树花

北京大学深圳医院超声科，广东深圳 518036

详细信息

作者简介:
马树花，硕士，主治医师，E-mail: 412011989@qq.com

计量
- 文章访问数: 2272
- HTML全文浏览量: 1038
- PDF下载量: 24
- 被引次数: 0
出版历程
- 收稿日期: 2018-04-27
- 刊出日期: 2018-07-01

Application of ultrasound-guided mini-percutaneous thermal ablation in the treatment of thyroid nodule

Shuhua MA

Department of Ultrasonic, Shenzhen Hospital of Peking University, Shenzhen 518036, China

摘要

摘要: 超声引导下热消融治疗甲状腺结节是一种安全有效的微创介入治疗技术，可治疗多种类型的甲状腺结节。主要方法有射频、微波、激光消融及无水乙醇注射治疗等，目前以射频消融使用最为广泛。激光消融是近年来发展起来的一种新的微创治疗方法，关于甲状腺结节激光消融治疗的文献报道尚少。本文将对上述几种消融方法治疗甲状腺结节的优、缺点进行综述，推荐甲状腺结节的最佳治疗方法—激光消融，为以后的研究提供参考。
- 甲状腺结节 /
- 射频消融 /
- 微波消融 /
- 激光消融 /
- 无水乙醇注射
Abstract: Ultrasound-guided percutaneous thermal ablation of thyroid nodule is a minimally invasive interventional therapy technique that is safe and effective and can treat various types of thyroid nodules. Its main treatment methods include radiofrequency, microwave, laser ablation and anhydrous ethanol injection, among which radiofrequency ablation is currently the most widely used. Laser ablation is a new minimally invasive treatment method developed in recent years, and there are few reports about its application in the treatment of thyroid nodules. In this thesis, a brief overview of advantages and disadvantages of these methods in the treatment of thyroid nodules was carried out, after which it was concluded that laser ablation was the best treatment for thyroid nodule, thus providing references for future studies.
- thyroid nodule /
- radiofrequency ablation /
- microwave ablation /
- laser ablation /
- anhydrous ethanol injection

HTML全文

参考文献(40)

[1]	Levine RA. Current guidelines for the management of thyroid nodules[J]. Endocr Pract, 2012, 18(4): 596-9.
[2]	Rastogi A, Bhadada SK, Bhansali A. Nodular goiter with multiple cystic and solid swellings[J]. Indian J Endocrinol Metab, 2012, 16(4): 651-3.
[3]	Kihara M, Hirokawa M, Masuoka H, et al. Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases[J]. Auris Nasus Larynx, 2013, 40(3): 308-11.
[4]	Lee S, Skelton TS, Zheng F, et al. The biopsy-proven benign thyroid nodule: is long-term follow-up necessary[J]. J Am Coll Surg, 2013, 217(1): 81-9.
[5]	Kim YS, Rhim H, Tae K, et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience[J]. Thyroid, 2006, 16(4): 361-7.
[6]	Yue W, Wang SR, Wang B, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: Safety and imaging follow-up in 222 patients[J]. Eur J Radiol, 2013, 82(1): E11-6.
[7]	Ritz JP, Lehmann KS, Schumann T, et al. Effectiveness of various thermal ablation techniques for the treatment of nodular thyroid disease--comparison of laser-induced thermotherapy and bipolar radiofrequency ablation[J]. Lasers Med Sci, 2011, 26(4): 545-52.
[8]	Valcavi R, Riganti F, Bertani A, et al. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients[J]. Thyroid, 2010, 20(11): 1253-61.
[9]	Papini E, Guglielmi R, Bizzarri G, et al. Treatment of benign cold thyroidnodules:a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up[J]. Thyroid, 2007, 17(3): 229-35.
[10]	Feng B, Liang P, Cheng Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies[J]. Eur J Endocrinol, 2012, 166(6): 1031-7.
[11]	Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients[J]. Eur Radiol, 2008, 18(6): 1244-50.
[12]	Sung JY, Baek JH, Kim YS, et al. One-step ethanol ablation of viscous cystic thyroid nodules[J]. AJR Am J Roentgenol, 2008, 191(6): 1730-3.
[13]	Kang TW, Rhim H, Kim EY, et al. Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy[J]. Korean J Radiol, 2009, 10(1): 34-42.
[14]	Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results[J]. Abdom Imaging, 2001, 26(4): 345-60.
[15]	Park SH, Yoon SK, Cho JH, et al. Radiofrequency ablation treatment for renal cell carcinoma: early clinical experience[J]. Korean J Radiol, 2008, 9(4): 340-7.
[16]	Mctaggart RA, Dupuy DE. Thermal ablation of lung tumors[J]. Tech Vasc Interv Radiol, 2007, 10(2): 102-13.
[17]	Varshney S, Sewkani A, Sharma S, et al. Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety[J]. JOP, 2006, 7(1): 74-8.
[18]	Bergamini V, Ghezzi F, Cromi A, et al. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas[J]. Am J Obstet Gynecol, 2005, 192(3): 768-73.
[19]	Lee JH, Kim YS, Lee D, et al. Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA) [J]. World J Surg, 2010, 34(7): 1488-93.
[20]	Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition[J]. AJR Am J Roentgenol, 2010, 194(4): 1137-42.
[21]	Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy[J]. Surgery, 2001, 130(6): 971-7.
[22]	Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma[J]. Ann Surg, 2006, 244(2): 296-304.
[23]	Dong BW, Liang P, Yu XL, et al. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study[J]. AJR Am J Roentgenol, 1998, 171(2): 449-54.
[24]	Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients[J]. Radiology, 2009, 251(3): 933-40.
[25]	Rosenberg C, Puls R, Hegenscheid K, et al. Laser ablation of metastatic lesions of the lung: long-term outcome[J]. AJR Am J Roentgenol, 2009, 192(3): 785-92.
[26]	Papini E, Bizzarri G, Pacella CM. Percutaneous laser ablation of benign and malignant thyroid nodules[J]. Curr Opin Endocrinol Diabetes Obes, 2008, 15(5): 434-9.
[27]	Valcavi R, Piana S, Bortolan GS, et al. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation[J]. Thyroid, 2013, 23(12): 1578-82.
[28]	Spiezia S, Vitale G, Di Somma C, et al. Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter[J]. Thyroid, 2003, 13(10): 941-7.
[29]	Døssing H, Bennedbæk FN, Hegedüs L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules[J]. Eur J Endocrinol, 2011, 165(1): 123-8.
[30]	Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue:US-guided percutaneous interstitial laser Ablation-A feasibility study1[J]. Radiology, 2000, 217(3): 673-7.
[31]	Jeannon JP, Orabi AA, Bruch GA, et al. Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review[J]. Int J Clin Pract, 2009, 63(4): 624-9.
[32]	Di Rienzo G, Surrente C, Lopez C, et al. Tracheal laceration after laser ablation of nodular goitre[J]. Interact Cardiovasc Thorac Surg, 2012, 14(1): 115-6.
[33]	Frasoldati A, Valcavi R. Percutaneous ethanol injection(PEI)in the treatment of thyroid cysts,nodules,and other neck lesions[M]. New York: Springer, 2013: 315-46.
[34]	Livraghi T, Paracchi A, Ferrari C, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Work in progress[J]. Radiology, 1990, 175(3): 827-9.
[35]	Livraghi T, Paracchi A, Ferrari C, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience[J]. Radiology, 1994, 190(2): 529-33.
[36]	Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy[J]. Thyroid, 2004, 14(2): 125-31.
[37]	Kim YJ, Baek JH, Ha EJ, et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors[J]. Eur Radiol, 2012, 22(7): 1573-8.
[38]	Kim DW, Rho MH, Kim HJ, et al. Percutaneous ethanol injection for benign cystic thyroid nodules: is aspiration of ethanol-mixed fluid advantageous[J]. AJNR Am J Neuroradiol, 2005, 26(8): 2122-7.
[39]	Kim DW, Rho MH, Park HJ, et al. Ultrasonography-guided ethanol ablation of predominantly solid thyroid nodules: a preliminary study for factors that predict the outcome[J]. Br J Radiol, 2012, 85(115): 930-6.
[40]	Alberti SGC, Miasaki FY, Paz-Filho G, et al. Changes associated with percutaneous ethanol injection in the treatment of thyroid nodules[J]. Endocr Pathol, 2011, 22(2): 79-85.